ArticleMaterials today. Bio2022

Non-viral CRISPR activation system targeting VEGF-A and TGF-β1 for enhanced osteogenesis of pre-osteoblasts implanted with dual-crosslinked hydrogel.

Guo Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.